Antibody research plays a critical role in virology, immunology, and therapeutic development. Below are structured FAQs addressing key methodological and analytical challenges in academic research, informed by current studies and technical guidelines.
Innovative design:
| Parameter | Masked Antibody | Activated Antibody |
|---|---|---|
| Binding affinity (KD) | >100 nM | 2-5 nM |
| Toxicity in vivo | Reduced liver uptake | Target-specific action |
Integrated approaches:
Case study: COVID-19 convalescent plasma trials prioritized IgG titers >1:320 for therapeutic efficacy, yet some patients with lower titers still showed clinical improvement .
Technical workflow:
Cohort stratification: In serosurveys, oversample high-risk subgroups (e.g., healthcare workers) to improve statistical power .
Antibody stability testing: Store recombinant antibodies at -80°C with 5% glycerol to prevent aggregation .
Data transparency: Publish raw optical density (OD) values and threshold calculations to enable cross-study comparisons .